Sign in
Enrolling by invitationNo phase

Swallowable camera capsule to image the small intestine in celiac disease

Tests a swallowed imaging capsule in people with celiac disease and healthy volunteers.

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule
Status
Enrolling by invitation
People taking part
108 people, planned
Started
16 Sept 2013
Expected to end
Jul 2030
Type of study
Interventional
Treatments tested
  • OFDI Capsule
Record updated
10 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy volunteers and people with suspected or diagnosed Celiac disease. They will swallow a capsule on a thin cord that takes images of the first part of the small bowel (duodenum).

Age
Healthy volunteers: over 18 years. People with Celiac disease: over 16 years.
Sex
All sexes can join.
Disease stage
Celiac disease that is clinically suspected or diagnosed, or healthy with no disease.

Main reasons for not taking part

  • Cannot swallow pills or capsules
  • Abnormal openings (fistulas) in the food pipe or bowel
  • Known narrowing of the food pipe or bowel smaller than the capsule
  • History of Crohn's disease of the bowel
  • Pregnant women

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Participant must be over 18 years for healthy volunteers
  • Participants must be over 16 years for patients with Celiac disease
  • Participant must be able to give informed consent

Who cannot take part

  • Participants with a history of intestinal Crohn's disease
  • Participants with an inability to swallow pills or capsules
  • Participants with esophageal or intestinal fistulas
  • Participants with known esophageal or intestinal strictures resulting in a luminal diameter smaller than the diameter of the capsule
  • Women who are pregnant

Where in United States

  • Massachusetts General HospitalBoston, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The study is being done to assess the tolerability and feasibility of a tethered OFDI capsule to image the duodenum.

Read full original descriptionShow less

A total of 108 participants (36 healthy and 72 with clinically suspected or diagnosed Celiac disease) will be asked to swallow the tethered capsule, while they are awake and unsedated and ask for their feedback. Images will be taken using the OFDI system while the capsule travels from the esophagus into the stomach and into the duodenum.

The group in the trial

  • OFDI Capsule ImagingTreatment being tested

    Participant will swallow the OFDI Capsule and imaging will be performed using the OFDI system.

    Treatment: OFDI Capsule

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Pilot Study for Imaging of the Duodenum Using an OFDI Capsule
Plain-language title
Swallowable camera capsule to image the small intestine in celiac diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
10 November 2026